CD19 and neoplasm: Further colocalization experiments demonstrated that PTGDS was highly expressed in CD19+ B cells, CD4+ T cells and CD8+ T cells, suggesting that its protective effect may be enhanced by the anti-tumour effects of B cells and T cells.